Biomerica, Inc. (BMRA) P/E Ratio History
Deep ValueTrading at -0.8x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 1995–2014
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, Biomerica, Inc. (BMRA) trades at a price-to-earnings ratio of -0.8x, with a stock price of $1.75 and trailing twelve-month earnings per share of $-1.31.
The current P/E is 100% below its 5-year average of 263.5x. Over the past five years, BMRA's P/E has ranged from a low of 28.2x to a high of 3040.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.0x, BMRA trades at a 104% discount to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.4x.
Relative to the broader market, BMRA trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BMRA DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BMRA Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
BMRA P/E vs Peers
Device suppliers, distribution, and services peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $17B | 30.5 | - | -25% | |
| $8B | 10.8Lowest | - | +143%Best | |
| $44B | 42.2 | 2.95Best | +23% | |
| $191B | 28.9 | 13.69 | +7% | |
| $138B | 38.8 | - | -5% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
BMRA Historical P/E Data (1995–2014)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2014 Q1 | Aug 31 2013 | $7.20 | $0.01 | 911.4x | +12% |
| FY2013 Q4 | May 31 2013 | $7.12 | $0.07 | 100.4x | -88% |
| FY2013 Q3 | - | $9.20 | $0.07 | 127.2x | -84% |
| FY2013 Q2 | Nov 30 2012 | $6.72 | $0.11 | 62.6x | -92% |
| FY2013 Q1 | Aug 31 2012 | $5.68 | $0.11 | 52.9x | -93% |
| FY2012 Q4 | - | $5.52 | $0.09 | 63.2x | -92% |
| FY2012 Q3 | Feb 29 2012 | $6.08 | $0.09 | 64.7x | -92% |
| FY2012 Q2 | Nov 30 2011 | $3.84 | $0.07 | 51.9x | -94% |
| FY2012 Q1 | Aug 31 2011 | $3.60 | $0.04 | 81.8x | -90% |
| FY2011 Q4 | - | $3.60 | $0.02 | 162.2x | -80% |
| FY2010 Q2 | Nov 30 2009 | $3.04 | $0.00 | 3040.0x | +274% |
| FY2010 Q1 | Aug 31 2009 | $3.36 | $0.03 | 106.3x | -87% |
| FY2009 Q4 | May 31 2009 | $5.52 | $0.05 | 109.5x | -87% |
| FY2009 Q3 | Feb 28 2009 | $4.08 | $0.14 | 28.2x | -97% |
| FY2009 Q2 | Nov 30 2008 | $4.80 | $0.12 | 38.6x | -95% |
| FY2009 Q1 | Aug 31 2008 | $7.92 | $0.14 | 56.4x | -93% |
| FY2008 Q4 | May 31 2008 | $8.40 | $0.25 | 33.5x | -96% |
| FY2008 Q3 | Feb 29 2008 | $11.20 | $0.19 | 58.2x | -93% |
| FY2008 Q2 | Nov 30 2007 | $12.32 | $0.19 | 64.0x | -92% |
| FY2008 Q1 | Aug 31 2007 | $12.00 | $0.21 | 56.6x | -93% |
| FY2007 Q4 | - | $6.40 | $0.09 | 69.6x | -91% |
| FY2007 Q3 | Feb 28 2007 | $4.96 | $0.07 | 69.9x | -91% |
| FY2007 Q2 | - | $3.60 | $0.06 | 64.9x | -92% |
| FY2007 Q1 | - | $4.00 | $0.04 | 111.7x | -86% |
| FY2006 Q4 | May 31 2006 | $3.20 | $0.04 | 89.4x | -89% |
| FY2006 Q3 | - | $3.84 | $0.05 | 82.1x | -90% |
| FY2006 Q2 | Nov 30 2005 | $3.76 | $0.05 | 71.9x | -91% |
| FY2006 Q1 | Aug 31 2005 | $3.76 | $0.04 | 94.0x | -88% |
| FY2005 Q4 | - | $3.52 | $0.02 | 165.3x | -80% |
| FY1998 Q4 | May 31 1998 | $15.04 | $0.00 | 25066.7x | +2982% |
| FY1998 Q3 | Feb 28 1998 | $18.00 | $0.05 | 348.2x | -57% |
| FY1998 Q2 | Nov 30 1997 | $18.48 | $0.08 | 226.2x | -72% |
| FY1998 Q1 | Aug 31 1997 | $21.52 | $0.11 | 192.7x | -76% |
| FY1997 Q4 | May 31 1997 | $25.52 | $0.13 | 202.5x | -75% |
| FY1997 Q3 | Feb 28 1997 | $24.00 | $0.18 | 133.3x | -84% |
| FY1997 Q2 | Nov 30 1996 | $28.00 | $0.17 | 164.7x | -80% |
| FY1997 Q1 | Aug 31 1996 | $37.04 | $0.17 | 217.9x | -73% |
| FY1996 Q4 | May 31 1996 | $17.52 | $0.16 | 110.2x | -86% |
| FY1996 Q3 | - | $17.04 | $0.08 | 215.7x | -73% |
| FY1996 Q2 | - | $15.04 | $0.06 | 254.9x | -69% |
| FY1996 Q1 | - | $17.52 | $0.03 | 604.1x | -26% |
| FY1995 Q3 | - | $10.00 | $0.03 | 339.0x | -58% |
Average P/E for displayed period: 813.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BMRA — Frequently Asked Questions
Quick answers to the most common questions about buying BMRA stock.
What is BMRA's P/E ratio?
Biomerica, Inc. (BMRA) trailing twelve-month P/E ratio is -0.8x, based on TTM diluted EPS of $-1.31. The 5-year average P/E is 263.5x and the historical range spans 28.2x to 3040.0x.
Is BMRA stock overvalued or undervalued?
BMRA trades at -0.8x P/E, below its 5-year average of 263.5x. At the 0th percentile of its historical range (28.2x–3040.0x), the stock is priced at a discount to its own history.
Is BMRA stock expensive?
No, BMRA is not expensive on a historical basis. The current P/E of -0.8x is below the 5-year average of 263.5x and sits at the 0th percentile of its valuation range.
What is BMRA's historical P/E range?
Over the past 5 years, BMRA's P/E ratio has ranged from 28.2x to 3040.0x, with a median of 64.0x and an average of 263.5x. The current P/E of -0.8x places the stock at the 0th percentile of this range. Full historical data spans 1995–2014.
How does BMRA's P/E compare to the S&P 500?
BMRA trades at -0.8x P/E versus the S&P 500 median of 25.3x. The 103% discount to the market suggests lower growth expectations or perceived higher risk.
How does BMRA's valuation compare to Healthcare peers?
Biomerica, Inc. P/E of -0.8x compares to the Healthcare sector median of 23.0x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is BMRA's PEG ratio?
BMRA PEG ratio is N/A, based on a P/E of -0.8x and EPS growth of -500.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is BMRA's earnings yield?
BMRA earnings yield is N/A, the inverse of its -0.8x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.